BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 453268)

  • 1. Uterine rupture with the use of vaginal prostaglandin E2 suppositories.
    Sandler RZ; Knutzen VK; Milano CM; Gleicher N
    Am J Obstet Gynecol; 1979 Jun; 134(3):348-9. PubMed ID: 453268
    [No Abstract]   [Full Text] [Related]  

  • 2. Uterine rupture with the use of vaginal prostaglandin E2 suppositories.
    Keller F; Joyce TH
    Anesth Analg; 1983 Nov; 62(11):1046. PubMed ID: 6578694
    [No Abstract]   [Full Text] [Related]  

  • 3. Uterine rupture with the use of vaginal prostaglandin E2.
    Elder MG
    Am J Obstet Gynecol; 1985 Oct; 153(3):342. PubMed ID: 3863485
    [No Abstract]   [Full Text] [Related]  

  • 4. Uterine rupture associated with the use of vaginal prostaglandin E2 suppositories.
    Keller F; Joyce TH
    Can Anaesth Soc J; 1984 Jan; 31(1):80-2. PubMed ID: 6581851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine rupture with the use of vaginal prostaglandin E2 for induction of labor.
    Claman P; Carpenter RJ; Reiter A
    Am J Obstet Gynecol; 1984 Dec; 150(7):889-90. PubMed ID: 6594931
    [No Abstract]   [Full Text] [Related]  

  • 6. Uterine rupture at term with vaginal prostaglandin E2.
    Valenzuela G; Hayashi RH; Lackritz RM; Soriero OM
    Am J Obstet Gynecol; 1980 Dec; 138(8):1223-4. PubMed ID: 7446633
    [No Abstract]   [Full Text] [Related]  

  • 7. Rupture of the cervix during prostaglandin termination of pregnancy.
    El-Etriby EK; Daw E
    Postgrad Med J; 1981 Apr; 57(666):265-6. PubMed ID: 7291112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uterine scar rupture in labour induced with vaginal prostaglandin E2.
    Bromham DR; Anderson RS
    Lancet; 1980 Aug; 2(8192):485-6. PubMed ID: 6106134
    [No Abstract]   [Full Text] [Related]  

  • 9. Third-trimester uterine rupture after prostaglandin E2 use for labor induction.
    Maymon R; Haimovich L; Shulman A; Pomeranz M; Holtzinger M; Bahary C
    J Reprod Med; 1992 May; 37(5):449-52. PubMed ID: 1507193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison between vaginal prostaglandin E2 suppositories and intrauterine extra-amniotic prostaglandins in the management of fetal death in utero.
    Scher J; Jeng DY; Moshirpur J; Kerenyi TD
    Am J Obstet Gynecol; 1980 Aug; 137(7):769-72. PubMed ID: 7405968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine rupture and labor induction with prostaglandin.
    Thiery M
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):914. PubMed ID: 3861095
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of postpartum uterine atony with prostaglandin E2 vaginal suppositories.
    Hertz RH; Sokol RJ; Dierker LJ
    Obstet Gynecol; 1980 Jul; 56(1):129-30. PubMed ID: 6966776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rupture of the uterus following treatment with 16-16-dimethyl E 2 prostaglandin vagitories.
    Jerve F; Fylling P; Stenby S
    Prostaglandins; 1979 Jan; 17(1):121-3. PubMed ID: 441421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
    Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
    Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 vaginal suppositories for therapeutic abortion.
    Newman C; Bailey CD; Ellinas SP; Anderson GG
    Adv Plan Parent; 1975; 10(1):34-8. PubMed ID: 1164986
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
    Hochman M; Laufe LE
    J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine hyperstimulation and rupture after induction of labour with prostaglandin E2. Case reports.
    Larsen JV; Brits CI; Whittal D
    S Afr Med J; 1984 Apr; 65(15):615-6. PubMed ID: 6584991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.